Storia in 1 fonti

Why Polaryx Therapeutics Stock Is Surging On Thursday? - Polaryx Therapeutics (NASDAQ:PLYX)

Polaryx Therapeutics (NASDAQ: PLYX) stock climbs on Thursday following a $10M private placement to launch its Phase 2 SOTERIA trial for rare lysosomal storage disorders.

Raccontata da

benzinga.com

Timeline cronologica

giovedì 28 maggio 2026·benzinga.com
Why Polaryx Therapeutics Stock Is Surging On Thursday? - Polaryx Therapeutics (NASDAQ:PLYX)
Polaryx Therapeutics (NASDAQ: PLYX) stock climbs on Thursday following a $10M private placement to launch its Phase 2 SOTERIA trial for rare lysosomal storage disorders.